Catabasis Pharma (CATB) Technical Analysis
NASDAQ:CATB
Current stock price
CATB Technical Rating and Analysis
We assign a technical rating of 1 out of 10 to CATB. CATB's overall performance in the market is below average. Also recent evolutions are not that positive. Both the medium and short term picture give negative signs.
- The long term trend is still negative, but the short term trend is neutral. It is advised to wait a little bit longer to see how this turns out.
- 100% of all other stocks performed better in the past year than CATB.
- CATB is one of the lesser performing stocks in the Biotechnology industry. 90% of 518 stocks in the same industry do better.
- CATB is currently trading near the lower end of its 52 week range, which is not a good sign. The S&P500 Index is trading in the upper part of its 52 week range, so CATB is lagging the market.
- In the last month CATB has a been trading in the 6.31 - 10.26 range, which is quite wide. It is currently trading in the middle of this range, so some resistance may be found above.
- Considerably lower volume is observed in the last couple of days.
CATB Weekly and Daily overview Charts
CATB Setup Rating and Analysis
Although the technical rating is bad, CATB does present a nice setup opportunity. Prices have been consolidating lately and the volatility has been reduced. There is very little resistance above the current price.
More info and screens
CATB Support and Resistance Analysis
8.45
2 important resistance areas can be observed.
- Resistance @9.54 from a horizontal line in the weekly time frame.
- A resistance zone ranging from 9.76 to 9.82. This zone is formed by a combination of multiple trend lines and important moving averages in the daily time frame.
CATB Technical Indicator Signal Analysis
The Technical Rating and Setup analysis above combine different indicators and trends in different timeframes. Individual signals from indicators may give more contradictive signals and should always be interpreted in the more global context.
| Indicator | Value | Signal | Comment |
|---|---|---|---|
| ChartMill Long Term Trend Indicator | DOWN | NEGATIVE | The long term trend for CATB is down. |
| ChartMill Short Term Trend Indicator | NEUTRAL | NEUTRAL | The short term trend for CATB is neutral. |
| ChartMill Relative Strength | 0.96 | NEGATIVE | CATB has a low relative strength, it was outperformed by 99.04% off all stocks on the market. |
| Simple Moving Average/SMA (20) | UP | MIXED | The current price of CATB is below the rising SMA(20). |
| Simple Moving Average/SMA (50) | DOWN | NEGATIVE | The current price of CATB is below a declining SMA(50). |
| Simple Moving Average/SMA (200) | UP | MIXED | The current price of CATB is below the rising SMA(200). |
| Relative Strength Index/RSI (14) | 43.29 | NEUTRAL | The RSI value for CATB is a neutral value. |
| Moving Average Convergence Divergence/MACD (12, 26, 9) | 0.12 | POSITIVE | The MACD value suggests CATB has a positive trend, although the MACD value is declining. |
| Stochastics (14,3) | 70.21 | NEUTRAL | The Stochastics value for CATB is a neutral value. |
| Average True Range in percent/ATR (20) | 8.66 | HIGH VOLATILITY | The high ATR as a percentage value for CATB suggests high volalility. |
CATB Chart- and CandleStick Pattern Analysis
CATB Technicals: Chart, Performance Metrics, Trend & Indicators
8.54
-0.64 (-6.97%)
Catabasis Pharma / CATB TA FAQ
What is the technical rating for CATB stock?
ChartMill assigns a technical rating of 1 / 10 to CATB.
What is the trend direction for CATB stock?
The current trend direction for Catabasis Pharma (CATB) is Bearish.
What is the RSI signal for CATB stock?
Catabasis Pharma (CATB) has an RSI value of 43.2904. This indicates that the stock is currently neutral.
What is the MACD signal for CATB stock?
The MACD indicator for Catabasis Pharma (CATB) has a value of 0.115533, indicating a bearish trend.
Can you provide the support and resistance levels for Catabasis Pharma?
Catabasis Pharma (CATB) has a resistance level at 9.54. Check the full technical report for our detailed analysis of CATB support and resistance levels.